Sanofi said last week it had entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice, a year after flagging ...
The newly merged company also formed a subsidiary known as Sanofi Pasteur, which is today one ... the patient at the heart of the company’s business conduct and is based on four key areas ...
you may benefit from opening a business credit card. A business credit card helps to keep personal and professional expenses separate, which makes things much easier come tax time. Plus ...
There are a lot of reasons why having a credit card for your business is helpful, from money-saving benefits to simplifying your expense management. On top of all the perks, these cards typically ...
Management is trying to decide further details such as whether to list the separated business on the Euronext Paris stock exchange. Sanofi’s leaders have also not yet decided what will go into ...
As Sanofi moves forward with talks to potentially sell a 50% stake its consumer health unit Opella, fears of job cuts and drug shortages have prompted a call for industrial action in the company ...
Here is a list of our partners and here's how we make money. Hotel business credit cards come with serious perks, like free stays, elite status, room upgrades and massive sign-up bonuses.
Caroline Lupini has been traveling the world with the help of credit card rewards since 2011. She has visited over 110 countries and is able to utilize her knowledge of credit cards and to make ...
Many business credit cards require a personal guarantee, ensuring that the business owner will pay off debt. While it protects the bank, a personal guarantee opens the business owner up to ...
The visit takes place after the maker of the pill, French pharma group Sanofi, said it was in talks to sell off its consumer health business to a US private equity firm. The deal has raised fears ...
In France, pharmaceutical giant Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to a US private equity firm. The sale is estimated at around 15 ...